{'fraction_non_alphanumeric': 0.02788339670468948, 'fraction_numerical': 0.005069708491761723, 'mean_word_length': 5.370967741935484, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Abrogation of spleen macrophage suppressive activity by 15-deoxyspergualin.

We studied the immunomodulatory mechanism of 15-deoxyspergualin (DSG), a novel antitumor agent. To assess this, we used a mixed culture of antigen-primed lymph node cells (LNC) and spleen cells (SPC). In normal or untreated conditions, SPC suppressed the proliferative response of LNC to the antigens. In contrast, SPC from DSG-treated animals did not show any suppressive activity. This suppression was mediated by adherent cells in SPC but the suppression mechanism was recovered when DSG-treated spleen macrophages were reconstituted with control spleen nonadherent cells. These data suggest that DSG abrogates nonspecific suppressive activity of spleen cells by acting on both adherent and nonadherent cells.